PinnyPeptide

Semaglutide vs Tirzepatide

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Semaglutide

Weight Management

GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes.

Peptide B

Tirzepatide

Weight Management

Dual GIP/GLP-1 receptor agonist delivering unprecedented weight loss and metabolic benefits.

Typical vial

3 mg

Typical dose

250-2400 mcg

Half-life

~7 days (168 hours)

FDA status

FDA approved. Ozempic (2017) for type 2 diabetes, Rybelsus (…

Typical vial

5 mg

Typical dose

2500-15000 mcg

Half-life

~5 days (120 hours)

FDA status

FDA approved. Mounjaro (2022) for type 2 diabetes, Zepbound …

Semaglutide effects

  • Significant and sustained weight loss (15-17% body weight in trials)
  • Improved glycemic control and reduced HbA1c
  • Reduced appetite and food cravings through central satiety signaling
  • Cardiovascular risk reduction (20% MACE reduction in SELECT trial)
  • Slowed gastric emptying for prolonged satiety
  • Improved insulin sensitivity and beta-cell function

Tirzepatide effects

  • Industry-leading weight loss (up to 22.5% body weight in trials)
  • Superior glycemic control with high rates of HbA1c normalization
  • Dual incretin receptor activation for complementary metabolic benefits
  • Significant reduction in waist circumference and visceral fat
  • Improved cardiometabolic risk factors (lipids, blood pressure)
  • Treatment of moderate-to-severe obstructive sleep apnea in obesity

Semaglutide side effects

  • Nausea (most common, especially during dose titration)
  • Vomiting and diarrhea
  • Constipation
  • Abdominal pain and dyspepsia
  • Pancreatitis (rare but serious)

Tirzepatide side effects

  • Nausea (most common, particularly during dose escalation)
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Injection site reactions

Semaglutide dosing ranges

Type 2 diabetes (Ozempic)

250-1000 mcg · Once weekly (SubQ) · Ongoing as prescribed

Weight management (Wegovy)

2400 mcg · Once weekly (SubQ, after 16-week titration) · Ongoing as prescribed

Tirzepatide dosing ranges

Type 2 diabetes (Mounjaro)

2500-15000 mcg · Once weekly (SubQ) · Ongoing as prescribed

Weight management (Zepbound)

2500-15000 mcg · Once weekly (SubQ, titrated over 20 weeks) · Ongoing as prescribed

Full Semaglutide guide → Full Tirzepatide guide →

Semaglutide vs Tirzepatide — common questions

What is the difference between Semaglutide and Tirzepatide?

Semaglutide: GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes. Typical dose 250-2400 mcg. Tirzepatide: Dual GIP/GLP-1 receptor agonist delivering unprecedented weight loss and metabolic benefits. Typical dose 2500-15000 mcg. Both fall under the Weight Management category.

Can you stack Semaglutide and Tirzepatide?

Stacking Semaglutide with Tirzepatide is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Semaglutide or Tirzepatide?

Semaglutide is typically dosed: Once weekly (SubQ) for Type 2 diabetes (Ozempic); Once weekly (SubQ, after 16-week titration) for Weight management (Wegovy). Tirzepatide is typically dosed: Once weekly (SubQ) for Type 2 diabetes (Mounjaro); Once weekly (SubQ, titrated over 20 weeks) for Weight management (Zepbound).

Are Semaglutide and Tirzepatide FDA approved?

Semaglutide: FDA approved. Ozempic (2017) for type 2 diabetes, Rybelsus (2019) oral for diabetes, Wegovy (2021) for chronic weight management. Tirzepatide: FDA approved. Mounjaro (2022) for type 2 diabetes, Zepbound (2023) for chronic weight management, and (2024) for obstructive sleep apnea in adults with obesity.

Related peptide comparisons

aod-9604 vs semaglutideftpp-adipotide vs semaglutidehgh-fragment-176-191 vs semaglutideretatrutide vs semaglutidesemaglutide vs survodutideaod-9604 vs tirzepatide

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free